In addition, no significant change in proCPU levels was observed in 12 patients with uncontrolled hypertension under an adequate dose of an ACE-inhibitor before and after the addition of an angiotensin-receptor blocker to their regimen [136]. This evidence concerns the gene ACE and Hypertension.